(Q46890824)

English

New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP)

scientific article published in January 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP) (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

2

Rajmund Adamiec

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

author name string

Joanna Kluz

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

language of work or name

Polish

0 references

publication date

1 January 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

published in

Postepy higieny i medycyny doswiadczalnej

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

volume

60

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

page(s)

15-23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

Identifiers

PubMed publication ID

16407790

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16407790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407790%20AND%20SRC:MED&resulttype=core&format=json

(Q46890824)

New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)